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Abstract
In this study, we evaluated the effects of trapidil on crush injury by monitoring nitric oxide,
malondialdehyde and transforming growth factor-Beta2 levels and by transmission electron mi-
croscopy in the rat sciatic nerve. The sciatic nerve was compressed for 20 sec by using a jewelers
forceps. Trapidil treatment groups were administrated a single dose of trapidil (8 mg/kg) intraperi-
toneally just after the injury. The crush and crush + trapidil treatment groups were evaluated on the
2nd, 7th, 15th, 30th and 45th days of the post-crush period. On the 7th and 15th days, damage in
thin and thick myelinated axons, endoneural edema and mitochondrial swelling were less severe
in the trapidil group histopathologically. These findings supported the idea that trapidil prevented
cell damage and edema at the injury site. Day/group interaction with regard to serum nitric oxide,
malondialdehyde and transforming growth factor-Beta2 levels did not show significant changes.
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In this study, we evaluated the eﬀects of trapidil on crush injury by monitoring nitric oxide,
malondialdehyde and transforming growth factor-β2 levels and by transmission electron microscopy in the rat sciatic nerve. The sciatic nerve was compressed for 20 sec by using a jeweler’s forceps.
Trapidil treatment groups were administrated a single dose of trapidil(8 mg/kg)intraperitoneally just after the injury. The crush and crush＋trapidil treatment groups were evaluated on the 2nd,
7th, 15th, 30th and 45th days of the post-crush period. On the 7th and 15th days, damage in thin and thick myelinated axons, endoneural edema and mitochondrial swelling were less severe in the trapidil group histopathologically. These ﬁndings supported the idea that trapidil prevented cell damage and edema at the injury site. Day/group interaction with regard to serum nitric oxide,
malondialdehyde and transforming growth factor-β2 levels did not show signiﬁcant changes.
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I t is well known that pathological events such as trauma, compression and crushing directly cause mechanical injury to nerve ﬁbers and deteriorate neuronal functions by impeding the intraneural microvasculature
［1, 2］. Morphological alterations occurring as conse-
quences of compression of the peripheral nerve could include demyelination and remyelination, axonal degenera-
tion and regeneration, focal, multifocal or diﬀuse nerve ﬁber loss and endoneural edema［3］. Additionally, direct mechanical injury or ischemia or both can cause acute endothelial injury that can result in endothelial edema, a granulocyte plug or microvascular thrombosis. These factors interrupt the reﬂow and can cause continuous ﬁber
 
injury. Moreover, endoneural edema may develop due to microvascular compression［2］. Toxic substances released from neutrophils and macrophages after injury can impair tissue protection in normal conditions and permit the accumulation of free oxygen radicals［3-9］.
The protective eﬀects of trapidil have been demon-
strated in the peripheral nervous system in the treatment of ischemia and reperfusion injury. This eﬀect of trapidil is related to its vasorelaxant eﬀect, to the inhibition of inﬂammatory responses via macrophage inactivation and probably to the elevation of nitric oxide(NO)levels which neutralize free superoxide anion radicals［3］.
Response to injury could be evaluated by measuring end products of NO, which play a role in tissue protec-
tion, malondialdehide (MDA) level, which is a lipid peroxidation sign, and transforming growth factor beta-2
(TGF-β2) level, which is thought to play a role in
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nervous tissue recovery.
Our search of the literature revealed no previous study about the eﬀects of trapidil on peripheral nerve crush injury. In this study, we evaluated the response to trapidil after a crush injury in the rat sciatic nerve histopathologically by transmission electron microscopy and biochemically by examining the end products of NO
(nitrite and nitrate), MDA and TGF-β2 levels.
Materials and Methods
 
The procedures were reviewed and approved by the Institutional Animal Care and Use Committee at the Mersin University Medical Faculty. In this study 81 female albino rats(10 weeks old and weighing 200-225 g)
were used. Seven rats without a crush injury were used as the control group. The crush and crush＋trapidil groups were each divided into 5 subgroups after the crush injury based on the regeneration period, on the 2nd, 7th,
15th, 30th and 45th days. Rats were anesthetized by ketamin HCl at a dose of 50 mg/kg intramuscularly. The sciatic nerve was exposed at the right gluteal region without any damage to the muscle tissue and crushed for 20 sec with a jeweler’s forceps(no:5)in sterile operative conditions［10］. Crush level was marked on the muscle by a 4/0 non-absorbable silk suture, and then the incision site was closed. Rats in the therapeutic groups were administrated a single dose of trapidil(8 mg/kg)(Rocor-
nal;Rentschler Biotechnologie GmbH, Laupheim, Ger-
many)intraperitoneally just after the injury. The dose of trapidil was chosen on the basis of the daily human dose and previous experiments that reported substantial beneﬁts［11］
The sciatic nerves were harvested on the 2nd, 7th, 15th, 30th and 45th days after the crush injury. A 5-mm section includ-
ing the crush site of the nerve tissue was dissected, ﬁxed in situ with 2.5  gluteraldehyde in 0.1 mol/L phosphate buﬀer(pH 7.2)at 4°C for 2 to 4 h, postﬁxed with 1 osmium tetroxide in phosphate buﬀer(pH 7.2)and dehy-
drated with serially increasing concentrations of alcohol.
The tissues were then washed with propylene oxide and embedded in Araldite 6005 (Ciba-Geigy, Summit, NJ,
USA). Semithin transverse sections of 1 to 2μm were cut with a glass knife in a LKB Nova ultramicrotome
(LKB-Produkter AB, Bromma, Sweden), stained with toluidine blue and observed with a Nikon Optiphot light microscope by an observer blinded to which group the
 
sections came from(Nikon Co., Tokyo, Japan). The same ultratome was used to obtain thin transverse sec-
tions(60-90 nm thick), which were contrast-treated with uranyl acetate and lead citrate and observed with a JEOL JEM 1200 electron microscope(JEOL, Ltd., Tokyo,
Japan).
Serum levels of nitrite and nitrate were measured as oxidized end products of NO based on the Griess reaction
［12］.
Blood samples were obtained via continuous catheter-
ization and immediately centrifuged at 4000 r.p.m. for 10 min. Serum samples were preserved at－70°C until they were used for the assay. Equal volumes of serum and iso-osmotic potassium phosphate buﬀer were ultraﬁltrated at 4000 r.p.m. for 45 min at room tempera-
ture. The ultraﬁltrate was collected and used in the test.
Nitrates were quantitatively converted to nitrites for analysis. Enzymatic reduction of nitrate to nitrite was carried out by using coenzymes(NADPH, FAD)in the presence of nitrate reductase in the incubation assay.N-1-
(naphthyl) ethylenediamine dihydrochloride, sul-
phanilamide and incubation solutions were mixed at a ratio of 1:1:2(v/v). These mixtures were incubated for 5 min at room temperature in dimmed light and measured at
λ＝540 nm. Sodium nitrite (1.00 mM)was used as a standard to determine nitrite, and potassium nitrate(80 mM)was used as a standard to determine nitrate-nitric oxide colorimetric assay(Roche, Mannheim, Germany).
Malondialdehyde levels indicating lipid peroxidation were determined by the thiobarbituric acid reaction. The principle of the method depends on measurement of the pink color produced by interaction of barbituric acid with malondialdehyde elabo-
rated as a result of lipid peroxidation. The colored reaction 1, 1, 3, 3-tetraethoxy propane was used as the primary standard. The determination of MDA levels was performed by the method of Yagi［13］. All biochemical measurements were performed in a blinded fashion.
β Immunoassay of TGF-β2 was designed for the sensitive and speciﬁc detection of biologically active transforming growth factorβ2(TGF-
β2) in an antibody sandwich format. In this format,
ﬂat-bottom plates were coated with TGF-βCoat mAb,
which binds soluble TGF-β2. A second antibody, anti-
TGF-β2 pAb, was added to complete the sandwich.
After washing, antibody conjugate (horseradish perox-
idase, TGF-βHRP)was added and bound the sandwich
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complex. Finally, the chromogenic substrate 3, 3’, 5,
5’-tetramethyl benzidine(TMB)was added. The amount of speciﬁcally bound TGF-β2 in the sample was propor-
tional to the color generated in the coupled oxidation-
reduction reaction and was quantitated against a standard curve generated with known amounts of TGF-β2. Using this assay, we quantitated biologically active TGF-β2 in serum in the range of 32-1,000 pg/ml(TGFβ2 E????
ImmunoAssay System, 143540, Promega Co., Madi-
son, WI, USA).
Factorial analysis of vari-
ance with 2 factors was used for the statistical evaluation of the data. The Bonferoni post hoc test was used to determine the meaningful diﬀerences. Data were analyzed for day/group interaction. Descriptive statistics of the results are given in Table 1, Fig. 1-3. Type 1 error rate was accepted as 0.05 in statistical calculation. SPSS(ver.
11.5)was used for calculations.
Trapidil after Crush Injury April 2005
 
Fig.1  The mean±SE for serum NO(μmol/L)for each group on each day is shown.
Table 1  Descriptive statistics for serum NO, MDA and TGF-β2
 
Day Group  n  
Serum nitrite/nitrate mean±SE
 
Serum MDA mean±SE 
Serum TGF-β2 mean±SE
 
Control 7 16.612±1.104  6.024±0.624  3.553±0.462
 
Cr  8 22.325±2.088  7.756±0.631  5.220±0.701 2 Cr＋Tr 8 33.699±8.084  8.721±1.425  6.720±0.800
 
Cr  7 19.439±1.889  5.230±0.442  6.330±0.598 7 Cr＋Tr 8 18.005±1.589  4.081±0.162  7.999±1.064
 
Cr  8 23.231±2.346  6.574±0.163  8.426±1.191 15 Cr＋Tr 7 20.436±3.687  7.616±0.577  8.624±0.882
 
Cr  7 33.930±9.488  5.801±0.566 14.069±2.192 30 Cr＋Tr 7 28.553±3.505  5.797±0.352 10.591±1.361
 
Cr  8 78.069±13.767 7.801±0.801 10.096±1.170 45 Cr＋Tr 6 92.473±21.639  9.665±1.407 13.410±1.572
 
Cr, crush applied;SE, standard error;Tr, trapidil applied.
Fig.2  The mean±SE for serum MDA(nmol/ml)for each group on each day is shown.
Fig.3  The mean±SE for TGF-β2(pg/ml)for each group on each day is shown.
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 Results
 
Ultrathin sections were taken from the crush site of each sciatic nerve. The myelin sheaths of thin and thick myelinated axons,
unmyelinated axons, endoneural edema and axonal mito-
chondria were evaluated for each group.
2nd day group:The ultrastructure of sciatic nerves of both the crush and treatment groups showed the greatest injury in this group. Injury seemed to be worse in thick myelinated axons in both groups. Myelin separation was the most prominent ﬁnding in thick myelinated axons. In thin myelinated axons myelin separation was less severe.
Endoneural edema and mitochondrial swelling were observed in both groups. Unmyelinated axons seemed normal in all the specimens in both groups(Figs. 4a, 4b).
7th day group:When compared with both groups of the 2nd day and the crush group of the 7th day, damage in thin and thick myelinated axons was less severe in the treatment group. Swelling of the mitochondria and edema of the endoneurium were less severe in the treatment group. Unmyelinated axons were normal in both groups
(Figs. 4c, 4d).
15th day group:There was mild myelin separation in the thin and thick myelinated axons of the treatment group. Edema of the endoneurium and swelling of the mitochondria were again mild compared with the treat-
ment and crush groups of the 2nd and 7th days and the crush group of the 15th day. The crush group of the 15th day was similar in severity of injury to the crush group of the 7th day. Again unmyelinated axons were normal in appearance(Figs. 4e, 4f).
30th and 45th day groups:Both the treatment and the crush groups showed milder damage signs when compar-
ed with both groups of the 2nd, 7th and 15th days. There was no major diﬀerence in the appearance of the degenera-
tion signs between the treatment and the crush groups for the 30th and 45th days. Myelin separation and edema were scarce in the treatment and crush groups in both groups. Unmyelinated axons were normal in appearance
(Figs. 4 g, 4h).
With regard to serum NO calculations, we found the day/group interac-
tion to be insigniﬁcant statistically(P＝0.700). Because of this result, we did not examine the diﬀerences between the days and groups separately. There was a meaningful diﬀerence between the days(P＝0.001). In both groups the diﬀerences between the 2nd and 45th, 7th and 45th,
15th and 45th, and 30th and 45th days were observed to be statistically meaningful(Fig. 1, Table 1).
With regard to serum MDA levels, the day/group interaction was not found to be meaningful statistically
(P＝0.353). Because of this result, we did not examine the diﬀerences between the days and groups separately.
The diﬀerence between the days was meaningful, and in both groups the diﬀerence was meaningful between the 2nd and 7th, 2nd and 30th, 7th and 15th, 7th and 45th,
and 30th and 45th days(Fig. 2, Table 1).
With regard to TGF-β2 levels, the day/group inter-
action was not found to be meaningful statistically(P＝
0.086). Because of this result, we did not examine the diﬀerences between the days and groups separately. The diﬀerence between the days was meaningful(P＝0.0001),
and in both groups the diﬀerences were found meaningful only between the 2nd and 30th, 2nd and 45th, 7th and 30th, 7th and 45th, and 15th and 30th days (Fig. 3,
Table 1).
Discussion
 
In the present study electron microscopic ﬁndings in trapidil-treated groups on the 7th and 15th days showed amelioration after a crush injury. On the other hand,
levels of NO, MDA and TGF-β2, which inform us about tissue damage and the healing process, were not found to be meaningful when compared statistically both within the groups and between the groups.
It has been reported that after a crush injury, endo-
neural edema in the peripheral nerve inﬂuenced the microenvironment by increasing the pressure, decreasing the blood ﬂow or changing the electrolyte concentration in the endoneurium. If the restoration of adequate circula-
tion is delayed, ischemia creates Wallerian-like axonal degeneration［14-18］. Degeneration in the myelin and axons was observed a week later in the lesion site and distal to it. It was also stated that in 3 weeks, most of the axons were regenerated and remyelinated, and func-
tional recovery was completed in 4-5 weeks［14, 19］.
Trapidil is well known as a vasorelaxant which prevents tissue damage by diminishing the vasospasm caused by a crush injury［20, 21］. In our study electron microscopic ﬁndings showed that myelin separation and endoneural and mitochondrial swelling were less prominent in the trapidil groups on the 7th and 15th days,which supported the notion of trapidil’s tissue protective eﬀects.
Adequate external pressure application to a peripheral
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 Fig.4  a and b, electron micrographs of a transverse section of a rat sciatic nerve from the crush site of the crush group and the crush＋
trapidil group on the 2nd day illustrating myelin separation(arrow), myelinated axons(A), mitochondrial swelling (S), endoneural edema(E)
and normal unmyelinated axons(U)(bars indicate 1.8μm);c and d, electron micrographs of the crush and crush＋trapidil groups on the 7th day illustrating the same ﬁndings, which are less severe in the latter group(bars indicate 1.8μm);e and f, electron micrographs of the crush and crush＋trapidil groups from the 15th day, again illustrating the same ﬁndings of lesser severity in the crush＋trapidil group(bars indicate 1.8μm and 0.75μm respectively), (N, Schwann cell nucleus;C, collagen ﬁbrils);g and h, electron micrographs of the crush and crush＋
trapidil groups on the 45th day illustrating milder signs of myelin separation and endoneural edema. Regenerating ﬁbers(RF)are also seen in the crush＋trapidil group(bars indicate 1.8μm).
41 Trapidil after Crush Injury April 2005
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nerve results in complete circulatory arrest［14］. In addition to direct mechanical injury, this condition also causes local ischemia and triggers biochemical reactions due to the microvascular endothelial damage［2］. The peripheral nerve responds to trauma by an inﬂammatory reaction with increased vascular permeability and intraneural edema. Epineural edema develops rapidly due to the early response of epineural blood vessels even in cases of mild trauma. In a serious trauma such as a crushing injury, a prominent increase in the endoneural ﬂuid pressure causes a short period of total or subtotal localized ischemia［1］. This process ends with the release of endogenous chemical mediators, increased vascular permeability and an impaired nerve/blood barrier［1, 16,
22］.
Biochemical and pathological changes develop as a result of oxidative stress and lipid peroxidation in the impaired nerve/blood barrier. Local ischemia in the tissue causes metabolic impairment, which in turn allows the production of the toxic oxygen metabolites such as super-
oxide anion, hydrogen peroxide and hydroxyl radicals by the polymorphonuclear leucocytes that inﬁltrated the lesion site. Free oxygen radicals and cytokines which are responsible for cell damage are released from neutrophils.
Additionally, neutrophils, by causing adhesion, impair the ﬂow mechanically by obstructing the capillaries. Thus endothelial function is impaired and vascular permeability increases［22］. We suggest that trapidil could attenuate those mechanisms by its prevention of neutrophil adhe-
sion.
After the injury, NO accelerates cell migration, facili-
tates angiogenesis and wound healing, causes vasodilata-
tion, has an antiatherogenic eﬀect by platelet aggregation inhibition, provides endothelial leukocyte adhesion and leukocyte activation and is an endogenic inhibitor of chemothaxis［4, 6, 8, 9, 23-25］. It takes part in neurogenesis and protection from neuronal damage［3,
26］.
It is reported that in mammals the axonal injury resulted in NOS upregulation dramatically in most of the central and peripheral neuron types. In particular, the inducible form of nitric oxide synthase(iNOS)is released in response to activation of cytokine and endothoxin, and increases NO synthesis to toxic levels in ischemia［26,
27］. Efron et al.reported that iNOS activity reached the maximum level on the 1 st day and decreased on the 3rd and 5th days［25］. Increase of NO in serum on the 2nd day in both the treatment and crush groups, in contrast
 
to the control group in our study, is in accordance with their results (Table 1).
It is reported that in ischemia/reperfusion injuries,
free superoxide anion radicals appeared in response to tissue damage, neutralized endogenous NO and moreover decreased iNOS activation. For this reason, end prod-
ucts of NO, nitrite and nitrate levels decreased after the peak level reached on the ﬁrst day［3, 25］. Serum NO level decreased in both groups on the 7th and 15th days in our study, which is in accordance with these studies.
On the other hand, trapidil’s eﬀect on serum NO levels in case of crush injury does not coincide with the results of Bagdatoglu et al., who described ischemia/reperfusion injury in which trapidil increased the release of nitrite and nitrate levels［3］. One reason for this disparity in ﬁndings is that the endothelial area aﬀected in a crush injury could be smaller than that in an ischemia/reper-
fusion injury, so the biochemical changes noted in the study by Bagdatoglu et al. were not meaningful statisti-
cally. The other reason may be that NO levels in their study were evaluated in the tissue. Furthermore, the mechanism of NO increase during the ﬁrst days after trapidil administration is not well understood.
In tissue ischemia and injury, endothelial cells, tissue mast cells, monocytes, circulatory neutrophils and platelets produce eicosanoids. From these, tromboxane A2, by inducing neutrophils increases the release of free oxygen radicals and by regulating CD11/CD18 activity provides diapedesis. Trapidil’s cell damage and edema preventive eﬀects at the injury site have been explained by some authors as the result of the inhibition of tromboxan A2 by producing a membrane-stabilizing eﬀect and the inhibition of an inﬂammatory response by macrophage inactivation［3, 23］. We interpret the histopathological signs on the 7th and 15th days, such as the milder degree of myelinated ﬁber damage, mitochondrial swelling and endoneural edema in the treatment group in our study, as trapidil’s protective eﬀects in nerve tissue. Mitochondrial changes in Schwann cells are thought to be caused by the induction of neutrophil-derived free oxygen radicals by tromboxane A2, and trapidil as a tromboxane A2 in-
hibitor might have decreased these eﬀects.
In crush injuries, lipid radicals get oxygenated and produce lipid peroxide radicals which transforms them to malondialdehyde(MDA)［4, 9］. MDA is used as a lipid peroxidation indicator in tissue injuries. In nerve injuries,
due to the excessive amount of lipids in nerve tissue,
MDA increases easily［3, 28］. In one study, the
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authors reported that serum MDA started to increase on the ﬁrst day, but then decreased to normal levels at the end of the ﬁrst week［3］. The higher levels of serum MDA on the second day of our study for both groups in contrast to the control group were consistent with this data(Table 1). Increasing MDA as well as NO levels on the 45th day were thought to be caused by the metabolic alterations occurred in the tissue healing process.
Cytokines take part in many biological activities such as inﬂammation, tissue regeneration, cell proliferation and wound healing［24］. Transforming growth factor-β
(TGF-β) is a cytokine released from activated macro-
phages during tissue injury, and it increases in ischemic conditions. This is thought to be an adaptive response to ischemic injury［29］. TGF-β2, a member of the TGF-β
family, is reported to play a role in wound healing and repair, and it additionally has neuroprotective eﬀects［24,
30］. Trapidil’s eﬀect on TGF-β2 has not been described in the literature. In our study, a gradual increase of TGF-β2 levels was observed in both groups after the second day as a predicted response to tissue healing(Fig.
3, Table 1). However, TGF-β2 levels did not show any diﬀerence according to the days between the crush and treatment groups. Thus our study did not show any evidence that trapidil decreased TGF-β2 levels.
In conclusion, our histological examination indicated that intraperitoneal administration of trapidil prevented cell damage and edema at the injury site. Because of the lack of harmony between the histological and biochemical results in this preliminary study, we hypothesize that the trapidil dose used in this study might have been below or just at the threshold of eﬀect and higher doses or multiple injections might show detectable alterations in the NO,
MDA and TGF-B2 levels.
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